HealthFDA Grants Historic Approval for Gene-Editing Treatment in Sickle Cell Disease The US Food and Drug Administration approved a groundbreaking gene-editing therapy for sickle cell disease, which affects hundreds of thousands of Americans.by Quincy Jon
HealthSickle Cell Disease: Could CRISPR’s Gene Therapy Editing Tech be the First Cure for It?by Isaiah Richard
ScienceSickle Cell Disease Treatment Involves Gene-Editing Treatment, Shows Promising Resultsby Sieeka Khan